<DOC>
	<DOC>NCT02232984</DOC>
	<brief_summary>The purpose of the study is to evaluate different ways to program around extracardiac stimulation.</brief_summary>
	<brief_title>Quadripolar CRT-D On Currently Approved Lead SystemS</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject is medically indicated for implantation with a BSC DYNAGEN or INOGEN X4 CRTD (or any future FDA approved BSC X4 CRTD) and already implanted with/scheduled to receive a commercially available quadripolar left ventricular lead Subject is willing and capable of providing informed consent and participating in all testing and study visits associated with this investigation at an approved center and at the intervals defined by this protocol Subject is age 18 or above, or of legal age to give informed consent specific to state and national law Subject has a known or suspected sensitivity to dexamethasone acetate (DXA) Subject is enrolled in any other concurrent study, without prior approval from BSC Women of childbearing potential who are or might be pregnant at the time of study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>CRT-D</keyword>
	<keyword>Quadripolar pacing</keyword>
</DOC>